Lotus Clinical Research Executive to Present on Opioid Sparing...

Dr. Neil Singla, Chief Scientific Officer of Lotus Clinical Research will discuss opioid sparing endpoints and criteria for submission of opioid-sparing labels to the FDA at the 11th Annual Pain and...(PRWeb August 22, 2017)Read the full story at http://www.prweb.com/releases/2017/08/prweb14618097.htm

Source: PRWeb: Medical Pharmaceuticals - August 22, 2017 Category: Pharmaceuticals Source Type: news